Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease

You are here

Home » Publications » Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer’s Disease

Griñán-Ferré C, Codony S, Pujol E, Yang J, Leiva R, Escolano C, Puigoriol-Illamola D, Companys-Alemany J, Corpas R, Sanfeliu C, Pérez B, Loza MI, Brea J, Morisseau C, Hammock BD, Vázquez S, Pallàs M, Galdeano C.,
2020
References: 
Neurotherapeutics. 2020 Jun 2. doi: 10.1007/s13311-020-00854-1.
  • Associated Personnel

    Coral Sanfeliu Pujol

    Research Scientist
  • Associated Research Groups

    Aging and Neurodegeneration

    Read more
  • Associated Departments

    Neuroscience and Experimental Therapeutics.

    The department studies the biological bases and molecular mechanisms of brain aging and brain pathologies, including neurodegenerative, cerebrovascular, and neuroinflammatory diseases. In the same way, it addresses the study of brain circuits and synaptic processes involved in neuropsychiatric disorders such as depression and schizophrenia.

    Read more